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Mobility is an essential part of a person’s functioning and independence. It encompasses
locomotive functions, but also the more basic functions of positioning and transferring.
Despite the availability of several mobility-related assessment instruments to date, there is a
need for assessment instruments with the specific capability to display the full range of
mobilisation. Our aim was to develop and validate a scoring instrument with hierarchical
composition where every score value stands for a defined mobility level.
Participants and Methods
A previously developed and validated pilot instrument was applied to assess patients (n =
113) admitted to an acute rehabilitation programme. Mobility was assessed during admis-
sion, subsequently at weekly intervals and at discharge to acquire a detailed status of mobil-
ity at multiple time points and individual mobilisation profiles over time. The scoring
instrument was then remodelled based on clinical criteria to establish an easy-to-use scor-
ing system with hierarchical composition. Psychometric properties were calculated using an
independent sample of 87 consecutive patients.
Results
Content validity could be affirmed. The psychometric tests demonstrated excellent conver-
gent validity with the three mobility items of the Barthel Index (r = 0.93), despite an ade-
quately lower correlation with the whole Barthel Index (r = 0.63). Adequate floor and ceiling
effects (20%) and a large responsiveness to change (|d| = 1.7, p < 0.001) between admis-
sion and discharge values were demonstrated. Inter-rater reliability was excellent (κ = 0.88).
Conclusions
The Charite´ Mobility Index (CHARMI) is a promising, easy-to-use hierarchical scoring
instrument assessing the full individual spectrum from immobility to unlimited mobility,
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including positioning, transfer and locomotion items. It allows for monitoring of
mobilisation.
Introduction
Mobility in its classical meaning is the ability to move freely. It is essential for social activities
and participation. From a clinical perspective, mobility encompasses locomotion abilities and
a range of basic activities, such as changing and maintaining body positions, as displayed in
the International Classification of Functioning, Disability and Health (ICF) [1].
In contrast, immobility is the cause and consequence of numerous medical complications
[2,3]. It leads to an increase in morbidity and mortality by infectious diseases, pressure ulcers,
contractures, thromboembolism, muscle atrophy, cardiopulmonary deconditioning, osteopo-
rosis, cartilage degeneration and many other negative sequelae, affecting nearly every organ
system or body structure [2–9]. Therefore, early mobilisation and rehabilitation should be an
integral part of every medical treatment concept, trying to maintain or improve a patient’s
functioning [10]. Early mobilisation and rehabilitation are associated with an improved func-
tional status and a shorter hospital stay [11–15]. However, this correlation is not limited to the
acute phase. An increase in gait speed by training is predictive for a substantial reduction of
mortality in elderly patients [16].
Between complete immobility and full mobility, there is a broad spectrum of individual
locomotive competencies, ranging from positioning in the bed, transfer to an upright position
and unimpaired movement. An analysis of the existing mobility assessment instruments
reveals the lack of a simple and practical but reliable assessment tool displaying the whole
range of mobility. There is a variety of existing tools, measuring different operationalised
aspects of mobility or mobility-associated competencies. Many of them regard mobility as a
part of a broader test battery; or they are originally designed for specific diseases (e.g. River-
mead Motor Assessment, Barthel Index, Functional Independence Measure) [17–22]. Some
assessment instruments test single mobility-related tasks as an indicator of global mobility
(e.g. Timed Up and Go Test) and therefore have high floor and ceiling effects, as well as a lim-
ited scale width in the acute care setting [23–25]. Some focus on other mobility aspects, such
as safety (e.g. Tinetti Test, Berg Balance Scale), requirement of assistance (e.g. Functional
Ambulation Categories), or restricted high-level motoric functions (e.g. High Level Mobility
Assessment Tool HiMAT) [26–31]. Only a few display the full spectrum of mobility, such as
the Elderly Mobility Scale (EMS), designed and validated for geriatric patients, and the de
Morton Mobility Index (DEMMI) [32–35]. The latter allows for a measurement using a Rasch
analysis-calculated (pseudo-)interval scale, which is an attractive feature, especially for scien-
tific use. However, the score requires a controlled assessment setting and is therefore not very
practical in clinical use. In addition, both the DEMMI and the EMS do not consider relevant
mobility tasks, such as climbing stairs and wheelchair mobility.
Another widely used global mobility assessment is the Rivermead Mobility Index (RMI)
[36]. It is an extension of the Rivermead Motor Assessment and poses 15 mobility-related
questions, in which each positively answered questions gains one point. The sum score is used
as a measure of mobility. The RMI encompasses a wide range of the mobility spectrum and is
based on the patients’ functional independence. A general problem regarding the use of sum-
scores is that the achieved score alone does not allow for reliable interpretation of the mobility
level, except for the highest and lowest sum-scores. For example, a sum score of 7 in the RMI
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may be interpreted as limited mobility, but it does not describe which functions precisely are
impaired.
Therefore, our aim was to develop and validate a novel, easy-to-use assessment instrument
based on ICF categories, which displays the whole spectrum of mobility in therapy-relevant
increments of function, and includes a hierarchical composition of the items scored.
Materials and Methods
Pilot Phase
In a first study phase, a pilot instrument was developed and validated in a small sample
(n = 36, previously published) [37]. This pilot instrument had seven independent (i.e. non-
hierarchical) mobility items, each with an intra-item rating in the form of a Likert scale. The
items were collected from existing assessment instruments. They were transfers in bed, sitting
on edge of bed, transfer from bed to chair, wheelchair mobility, standing, walking and climbing
stairs. The score was applied as a standard assessment tool within the acute care rehabilitation
(ACR) programme of a university hospital. Over the course of 1 year 113 immobile patients
were consecutively assessed during admission, at weekly intervals and at discharge. Every
mobility task was assessed according to the time and resources needed for mobilisation, such
as assistance or mobilisation aids. The resultant longitudinal mobilisation profiles were docu-
mented. Based on these profiles, our novel hierarchical assessment tool was developed.
Development Phase
Table 1 displays the criteria which were chosen as the basic requirements for the final assess-
ment instrument.
With the aim of better clinical applicability, the intra-item scaling of the pilot instrument
was abolished as a condition for a hierarchical item sequence. The general item selection was
maintained; however, the item walking needed further differentiation to avoid a bunching of
scores in this item. The item sequence was arranged in hierarchy according to levels of mobil-
ity by logical judgement. The goal was to represent the steps of the most realistic sequence of
mobility re-gain during a mobilisation and rehabilitation process. Consecutively the sequence
of every two items in a row was verified on the basis of the previously acquired mobilisation
profiles. Finally, a short manual was compiled, and a logical revision of the score with the acro-
nym CHARMI was performed.
Table 1. Basic requirements for the final assessment instrument.
Face validity • Displaying full spectrum of mobilisation
• Inclusion of positioning and transfer abilities
Logical validity • Focus on the independence of functioning
• Item definition and item-to-item differentiation by established classification




• Simple clinical applicability
• Hierarchical composition
• Interprofessional applicability
• Assessment integration in regular therapy procedures
• Time efficiency of scoring
doi:10.1371/journal.pone.0169010.t001
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Validation Phase
Before testing the psychometric properties of the CHARMI, content validity was re-evaluated
by a panel of subject matter experts. Eight experts (four physicians and four physiotherapists,
each with at least 3 years of experience in ACR), who were not involved in the development
process of the instrument, answered a dichotomous question about the concordance of the
instrument and the measured construct. Content validity was quantified using Lawshe’s
method [38]. The content validity ratio (CVR) is the transformation of a proportional level of
agreement depending on how many experts within a panel rate an item as being essential.
CVR values range between −1 (perfect disagreement) and +1 (perfect agreement) and are put
into relation with a reference value CVRcritical, which is 0.75 in a panel with eight experts
[38,39].
For further psychometric testing, CHARMI was applied on a sample of consecutive immo-
bile patients of the same ACR programme for 12 months. All patients, who were immobile at
admission (i.e. who were not able to stand or walk) and completed their individual ACR plan,
were included (n = 87). Pre- and post-rehabilitation assessments using the CHARMI and
Barthel Index were conducted. Sample characteristics and normative data were analysed.
Construct validity was calculated using a correlation of the CHARMI and Barthel Index. In
comparison, the correlation of the CHARMI and the score of the three isolated mobility items
of the Barthel Index (transfers bed to chair and back, mobility on level surfaces and ability to
climb stairs) was calculated. Although the Barthel Index as a whole includes ADL and body
functions which are not related to mobility, the correlation with the isolated Barthel Index
mobility items indicates convergent construct validity. Confidence intervals of the correlation
coefficients were calculated using Fisher’s transformation.
The assessments at admission as well as the re-assessments using the CHARMI at patients’
discharge included floor and ceiling effect calculations. Floor effects appear when there is a
bunching of scores at the lowest index values (relevant at admission), whereas ceiling effects
are measured by the percentage of the highest possible value (relevant at discharge). A percent-
age up to 20% is considered acceptable; more than 20% is poor [40].
Responsiveness to change was determined by interferential statistics using the paired sam-
ple Wilcoxon test. The distribution-based parameter of Cohen’s d was calculated to comple-
ment the hypothesis testing with an effect size as an indicator for the measure’s clinical
relevance. In a simplified grading, |d| values over 0.8 represent a large effect size [41].
In a subgroup of 30 patients, the inter-rater reliability between the rating of a physician and
a physiotherapist was tested using Cohen’s kappa statistics. Kappa describes the concordance
of two variables with a value between 0 and 1, where higher values represent a higher concor-
dance [42]. The testing was conducted consecutively until the defined subgroup sample size
was reached. Despite possible differences in the patients’ performance the testing was per-
formed as a test-retest situation to reach optimal blinding of the assessors.
The ACR plan and the ACR length of stay are individually planned and adjusted to the
patients’ functional status, including their mobility level. CHARMI scores at admission were
tested for their prognostic validity with regard to the length of stay in ACR. This was deter-
mined by Spearman’s rank correlation coefficient, where a positive or negative coefficient
between +1 and -1, unequal to 0, quantifies the predictive value.
For reasons of patient safety, all assessments were performed in regular physiotherapy
units, except for assessments performed by the physician during the inter-rater reliability tests.
All testers were intensively trained in the application of the CHARMI and were experienced in
mobilisation and ACR. The staff involved in the instrument’s development and validation sta-
tistics were not involved in the assessment procedures.
Introduction of the Charite´ Mobility Index (CHARMI)
PLOS ONE | DOI:10.1371/journal.pone.0169010 December 22, 2016 4 / 13
The German language version was used for the validity tests. An English-language version
was established using a structured translation, re-translation and comparison process [43].
The study is registered at the German Clinical Trials Register (Registration number
DRKS00010046). The institution’s ethics committee approved the study (vote number
EA1/234/12). The participants provided general written consent to the use of their (pseudony-
mised) data for scientific reasons together with their respective medical treatment contract.
The medical data used in this study was data of the clinical routine, obtained and used in the
routine treatment processes, therefore no additional written consent was needed to be
obtained for its analysis. The ethics committee approved this procedure according to the data
protection law of Berlin (Berliner Datenschutzgesetz), provided that personal data is pseudo-
nymised, pseudonymised data is not provided to a third party, and the project is limited to the
concerned hospital. Thus, restrictions apply concerning data availability. Data are available
from the Charite´ Universita¨tsmedizin Berlin Institutional Ethics Committee, Charite´platz 1,
10117 Berlin, Germany, for researchers who meet the committee’s criteria for access to the
data (contact via the corresponding author; email to max.liebl@charite.de).
The data were analysed using SPSS Statistics version 22 (IBM, Chicago, IL, USA) and MS
Office Excel 2010 (Seattle, IL, USA).
Results
The revision of the pilot instrument by means of the above mentioned criteria resulted in a
scale from complete immobility to full mobility. Each item was given a rank, beginning from 0
(represents complete immobility).
Item-to-item differentiation was elaborated using the categories and subcategories of the
chapter d4 (mobility) in the ICF [1]. Due to their therapeutic relevance in the early course of
mobilisation, the mobility items regarding transfers were divided into the following: transfers
in bed, defined as rolling from the back to the side; active transfer to edge of bed; the ability to
maintain a sitting body position (sitting on edge of bed); and standing up. The transfer from bed
to chair was included as a separate item because patients with impaired functions of the lower
extremities need this function as the basis of any independent wheelchair mobility. Walking,
as the major locomotion ability, was differentiated into four separate items defined by walking
distance based on the corresponding ICF subcategories. Climbing stairs was initially added as
highest locomotive ability.
The item sequence was arranged according to hierarchy by logical judgement and then
rearranged after double-checking the sequential arrangement of each two items according to
the mobilisation patterns. Consequently, the items sitting on edge of bed and transfer to edge of
bed were rearranged with the active transfer given the higher value, and the item climbing stairs
was sorted in between walking over 50 m and full mobility.
The item wheelchair mobility could not logically be included in the hierarchical sequence.
However, from a clinical and rehabilitation point of view, there was the need to consider it as a
mobility skill of major importance. Therefore, we decided to operationalise wheelchair mobility
outside of the sequential hierarchy. Independent wheelchair mobility is optionally encoded
with an additional “W” after the digit of the assessment score.
The exemplary sequential conduct of the assessment was as follows. The patient starts in
the lying position and is requested to turn from the back to the side (1 point) and then to sit up
to the edge of the bed. If this is not possible, assistance will be given to sit up, and the patient is
requested to sit at the edge of the bed freely for 30 seconds (2 points). Sitting up and sitting
freely for 30 seconds without assistance receives 3 points. As a next step, the patient is asked to
transfer to a chair or wheelchair (4 points) and then to stand up and keep the upright standing
Introduction of the Charite´ Mobility Index (CHARMI)
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position for 30 seconds (5 points). Then locomotion abilities are the next sequential tasks. The
patient is requested to start walking, and the walking distance is measured in three ICF-based
distance sections (6 points: within the room, under 10 m; 7 points: inside the home or within
the ward, 10–50 m; 8 points: outside the home or the ward, over 50 m). Nine points are
achieved by walking one flight of stairs, and 10 points are given for full mobility with walking
long distances over 1 km.
The use of assisting appliances (e.g. sliding boards for transfer, walking aids, rollators) is
permitted in the assessment setting. However, the autonomous accomplishment of the mobil-
ity tasks is crucial. Any help or assistance involving other persons counts as failed task. The
highest continuously achieved value determines the achieved score.
A patient who is capable of walking with crutches independently, without being able to
transfer into a standing position in the absence of assistance, cannot receive more than 4 points
(transfer from bed to chair).
A logical review of the instrument with regard to the a priori defined criteria and inter-item
discrimination, with the use of the ICF codes, was performed, and a short manual was written
(Tables 2 and 3).
Table 2. Differentiation of CHARMI items by ICF subcategories.
Score Item ICF Group Categories Subcategories
0 Complete immobility - - -
1 Transfers in bed Changing and maintaining body
position (d410-d429)
d420 Transferring oneself d4201 Transferring oneself while lying
2 Sitting on edge of
bed
Changing and maintaining body
position (d410-d429)
d415 Maintaining a body position d4153 Maintaining a sitting position
3 Transfer to edge of
bed
Changing and maintaining body
position (d410-d429)
• d410 Changing basic body
position
• d415 Maintaining a body
position
• d4103 Sitting
• d4153 Maintaining a sitting position
4 Transfer from bed to
chair
Changing and maintaining body
position (d410-d429)
d420 Transferring oneself d4200 Transferring oneself while sitting
5 Standing up Changing and maintaining body
position (d410-d429)
• d410 Changing basic body
position
• d415 Maintaining a body
position
• d4104 Standing
• d4154 Maintaining a standing position
6 Walking up to 10 m Walking and moving (d450-d469) d450 Walkinga d4500 Walking short distances
7 Walking 10 to 50 m Walking and moving (d450-d469) • d450 Walking
• d460 Moving around in
different locationsa
• d4500 Walking short distances
• d4600 Moving around within the home
8 Walking over 50 m Walking and moving (d450-d469) • d450 Walking
• d460 Moving around in
different locationsa
• d4500 Walking short distances
• d4602 Moving around outside the home
and other buildings
9 Climbing stairs Walking and moving (d450-d469) d455 Moving arounda d4551 Climbing
10 Full mobility Walking and moving (d450-d469) d450 Walkinga d4501 Walking long distances
+W Wheelchair mobility Walking and moving (d450-d469) d465 Moving around using
equipment
-
All displayed groups, categories and subcategories fall into chapter d4 (mobility) in the component d (activities and participation) of the ICF (International
Classification of Functioning, Disability and Health).
aWhen using mobilisation aids, d465 (Moving around using equipment) also applies.
doi:10.1371/journal.pone.0169010.t002
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Validation Phase
Table 4 shows the demographic data of the sample and the normative data of the ACR sample
for CHARMI.
Table 3. Charite´ Mobility Index [43].
CHARMI Short Manual
1. Count the best mobility item that can be performed without assistance.
2. Aids may be used.
3. Count wheelchair mobility separately (e.g. 4+W).
0 Complete immobility
1 Transfers in bed turning from back to side
2 Sitting on edge of bed sit 30 s, transfer may need assistance
3 Transfer to edge of bed transfer into sitting position
4 Transfer from bed to chair
5 Standing up with standing for 30 s
6 Walking up to 10 m e.g. within a room
7 Walking 10 to 50 m e.g. within a ward or inside the home
8 Walking over 50 m e.g. outside a ward or the home
9 Climbing stairs  1 flight of stairs
10 Full mobility  1 km
+W Wheelchair mobility
doi:10.1371/journal.pone.0169010.t003
Table 4. Sample characteristics and normative data of ACR sample for CHARMI.
Demographic dataa n = 87
Female sex 47 (54%)
Age (years) 59 ± 16.3 [13–88]
Body mass index 27.1 ± 7.1 [15.2–50.9]
Hospital length of stay 60.5; 78.8 ± 59.1 [20–313]
ACR length of stay 29; 36.6 ± 28.8 [8–195]
Intensive care treatment before ACR (%) 27.6
Normative data of ACR sampleb n = 87
CHARMI at admission to ACR 3 [1;4]
CHARMI at dismissal 6 [5;8]
Barthel Index at admission to ACR 45 [30;55]
Barthel Index at dismissal 72.5 [60;75]
Sample characteristics by transferring discipline n (%)
Orthopaedic surgery 25 (28.7%)
Traumatology 21 (24.1%)
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Content validity was confirmed by independent experts in the field of ACR. The CVR was
calculated with CVR = 1 and therefore lies above the critical value of 0.75, indicating concor-
dance of the instrument and the measured construct. The convergent construct validity of the
CHARMI with the three mobility-related items of the Barthel Index (transfers bed to chair and
back, mobility on level surfaces, stairs) were confirmed as excellent (r = 0.93). The calculated
correlation with the whole Barthel Index, which predominantly assesses non-mobility ADL
functions, was considerably lower (r = 0.63).
Responsiveness to change was determined by comparison of the CHARMI values before
and after ACR. The median CHARMI score at admission was 3 (interquartile range 1;4) and at
dismissal 6 [5;8]. Seventy-eight of the 87 patients increased their score, nine stayed on the
same level, and no score decreased (78 positive ranks, 0 negative ranks). Interferential statistics
proved a highly significant change with a very large effect size (|d| = 1.7; p< 0.001).
The inter-rater reliability between one physician and one physiotherapist was tested in a
subgroup (n = 30). In 8 of the 11 single items, there was an exact agreement between the two
raters. In three items (transfer to edge of bed, walking up to 10 m, walking 10 to 50 m), there
were score differences. The maximum difference was one score point. The overall inter-rater
reliability was excellent (κ = 0.88).
Floor and ceiling effects occurred during admission in 20% of cases. This is interpreted as
just adequate. With a percentage of 3%, the ceiling effects at discharge were not relevant.
The analysis showed a significant negative correlation between the CHARMI admission
scores and the ACR length of stay (r = -0.53; p< 0.01). Hence, the CHARMI score can be
interpreted as a prognostic parameter for the length of a patient’s ACR stay. Table 5 shows the
major results.
The forward-translation of the German version into the English version was conducted by
an independent health professional. Another person, also not part of the authoring team, con-
ducted a back-translation. According to the simplicity of the items, there was a complete agree-
ment of both the original and back-translated version.
Discussion
Relevance of the Study
The CHARMI is an assessment instrument to display the full range of mobility in therapy-rele-
vant steps. It is based on independence in mobility and thus has an ability-oriented rather than
a disability-oriented approach. The CHARMI uses ICF criteria to differentiate levels of
mobility.
Table 5. Major results: Psychometric properties of the CHARMI.
Content validity CVR = 1
Convergent construct validity with Barthel Index mobility items r = 0.93
(Discriminant) construct validity with whole Barthel Index r = 0.63
Responsiveness to change |d| = 1.7; p < 0.001
Inter-rater reliability (n = 30) κ = 0.88
Floor, ceiling effects (admission) 20%, 0%
Floor, ceiling effects (discharge) 0%, 3%
Predictive value of CHARMI at admission for ACR length of stay r = -0.53; p < 0.01
ACR: acute care rehabilitation.
doi:10.1371/journal.pone.0169010.t005
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The CHARMI is a valuable addition to regularly used assessment instruments measuring
functioning and mobilisation. Up until today there has not been a practical mobility assess-
ment tool for measuring mobility in acute care rehabilitation. The CHARMI fills this gap. Its
comprehensive design and easy application give it practical relevance. Its practical usability
combines with an excellent representation of the actual status of mobility of the patient. Any
given score value corresponds with a mobility level, and the score alone will allow for an inter-
pretation of the functioning in a given situation.
Changes of mobility levels and the course of mobilisation can sensitively be depicted.
Together with the hierarchical scoring in therapy-relevant steps this allows for a valid monitor-
ing of mobilisation. The CHARMI can be used by interprofessional teams, which makes the
instrument well suitable in clinical settings. It can be used for goal setting and goal attainment
scaling, which are increasingly important aspects of physiotherapeutic and other mobilisation
treatments.
Discussion of the Results
The general scope of clinical measurements can be divided into discrimination, prediction and
evaluation. The former two are usually evaluated with the classical test quality criteria objectiv-
ity, reliability and validity [44]. However, assessment instruments designed for evaluation
additionally have to determine changes of the measured quantity sensitively. Hence, respon-
siveness to change is a quality criterion of major importance for them. The CHARMI excel-
lently fulfils these criteria in the current sample and is therefore very well suitable for the
operationalisation of the mobility gain through the course of early rehabilitation interventions.
It also is the basis for the presumption of the transferability to other samples.
Before using the instrument in samples with (known or expected) distinct floor or ceiling
effects, there should precede a logical verification of its applicability. In the intensive care, for
example, assessments that measure assisted mobilisation or even tolerance of passively reached
mobility should be recommended. However, the CHARMI may be of use in intensive care
unit patients as a descriptive measure or with regard to mobilisation goal setting and goal
attainment scaling.
Structure and Items of the Instrument
The measured construct is the independent functioning in mobility by definition and sup-
ported by the tested content validity. To that effect, and in favour of clinical usability, some
aspects of mobility are not taken into account in the assessment. For example, these are the
dependency on mobilisation aids or assistance. In particular situations, it may be relevant to
assess the efforts in personnel and time or to discriminate non-professional and professional
assistance or even the necessity of more than one assisting person for mobilisation. Mental
functions and mobility restriction due to medical needs, such as full or partial weight bearing,
are only considered in the CHARMI as a limitation of independent mobility functions. Those
aspects are left unconsidered mainly to avoid further complexity. The advantage is that the
assessment gives a global rating of the everyday mobility range a patient can actually reach,
whereas many other assessment instruments test detailed or partial mobility aspects without
regarding the reality of everyday functioning. Despite the use of ICF items for the single ranks,
ICF Qualifier scales were not used for scoring to maintain the instrument’s easy applicability.
The same applies for any additional coding of environmental factors like barriers and facilita-
tors or even performance- or capacity-encoding qualifiers.
The single items of the CHARMI correspond to categories and subcategories of the chapter
d4 (mobility) of the ICF. For reasons of better responsiveness to change and to achieve better
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clinical usability, we decided to display the order of therapeutic mobilisation rather than the
sequence of tasks a healthy person would perform while standing up. Between the items sitting
on edge of bed and transfer to edge of bed, the transfer reached a higher value. A potential physi-
ological explanation could be that an active contraction of the core muscles is needed to sit up,
whereas sitting itself can be performed with less muscle strength. Neuronal and proprioceptive
functions also influence the degree of trunk stability. The differentiation of both items is there-
fore therapeutically relevant.
The differentiation of “walking” is classified into three items, each with a specific distance
range, defining the appropriate assignment based on the ICF subcategories d4500 (walking up
to 10 m/short distances), d4600 (walking from 10 to 50 m/within the home) and d4602 (walk-
ing more than 50 m/outside the home).
The full score (10) was defined as the equivalent to the ICF subcategory d4501 (walking
long distances). Accordingly, the required walking distance for full mobility would be
more than 1 km. Strictly speaking, it represents a fourth “walking” item, and one could
argue that it requires less functional ability to ambulate a kilometre than to climb stairs.
Yet, in this sample, the mobilisation profiles clearly show that climbing stairs is being inde-
pendently managed by the majority of patients before reaching the capacity for walking
long distances.
The time needed for the assessment, when individually performed, may vary greatly and is
dependent on the patient’s level of mobility. That may imply time spans of up to 15 minutes in
some cases. However, the average testing time in the acute rehabilitation unit is less than 5
minutes, according to the authors’ experience. Assessment requires the availability of neces-
sary technical appliances, such as walking aids regularly used by the patients and access to
facilities for measuring the walking distance and the possibility of climbing stairs. For testing
the transfer tasks, a bed or examination table and a chair are required. The assessment can be
performed as clinical observation integrated into the regular physiotherapy units or during
nursing interventions, thus avoiding loss of time.
Limitations
Usually, assessment instruments are tested and validated with samples that are specified by a
group of similar diagnoses. In this study, the sample was deliberately not selected according to
the patients’ ICD (International Classification of Diseases)-based diagnoses. The focus was laid
instead on the homogeneity of their functional loss in mobility. An acute rehabilitation pro-
gramme with a mixed sample of patients was chosen because a wide range of mobility limita-
tions was sought. On the other hand, the ACR unit is the appropriate setting for the
longitudinal exploration of an instrument that assesses mobility. In future efforts, we aim to
validate the CHARMI in different patient groups according to their diagnoses, irrespective of
their functional status.
The authors aimed with utmost effort to separate the staff involved in the development
from the persons performing the testing. Yet, this has to be taken into account as a potential
bias, as well as the limitation to one location and one sample.
The floor effects at admission can formally be rated as adequate, but with 20% of all admis-
sion scores they are in fact very close to being rated as poor. Due to the characteristics of the
sample at an acute rehabilitation programme, in which patients are transferred just because
they are immobile, this can be regarded as logical. Otherwise, it can also indicate the need for a
further differentiation of the item “complete immobility”. However, this would possibly impair
the focus on independence, as discussed above concerning the use of CHARMI in the intensive
care setting.
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Due to the ordinal scale and a missing intra-item differentiation (e.g. with Likert scales),
the CHARMI may be inferior to instruments with a (pseudo-)interval scale, such as the
DEMMI, for scientific use, especially if statistical analyses require higher scale of measurement.
However, in the clinical setting, where there is a need to assess the overall function and longi-
tudinal mobilisation developments, the CHARMI may be more useful as it covers the thera-
peutic steps of mobilisation and has a high responsiveness to change.
Current Use of the Instrument
The CHARMI is currently being introduced in three campuses within the Charite´ University
Hospital in Berlin, Germany, as a standard assessment of mobility, as well as for goal setting
and goal attainment scaling in physiotherapy. More than 160 physiotherapists apply the instru-
ment in more than 40,000 patients per year on a computer-based documentation of the assess-
ments and goals. The authors expect to be able to present more validation data in different
samples and mobility-related studies in the future.
Conclusion
The CHARMI is a valuable clinical instrument to assess the level of mobility when focussing
on independent functioning. It displays a wide spectrum of mobility in therapeutically relevant
steps and combines the advantage of clinical applicability with high test quality criteria.
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